A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Sutezolid (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 27 Sep 2017 Status changed from not yet recruiting to recruiting.
- 07 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 25 Sep 2017.
- 28 Jun 2017 New trial record